Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention

JAMA

Volumn 305, Issue 18, 2011, Pages 1882-1889

  Borden, William B ^a   Redberg, Rita F ^b   Mushlin, Alvin I ^a   Dai, David ^c   Kaltenbach, Lisa A ^c   Spertus, John A ^d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE; ANTITHROMBOCYTIC AGENT;

AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG EFFICACY; FEMALE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPTIMAL MEDICAL THERAPY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; THERAPY; TREATMENT RESPONSE; ANGINA PECTORIS; CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; HEART CATHETERIZATION; MIDDLE AGED; QUALITY OF LIFE; REGISTER; STATISTICS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; CLINICAL TRIALS AS TOPIC; CORONARY ARTERY DISEASE; FEMALE; HEART CATHETERIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; QUALITY OF LIFE; REGISTRIES; STENTS; UNITED STATES;

EID: 79955823001     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.601     Document Type: Article

References (43)

1. Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ. 2000;321(7253):73-77. (Pubitemid 30438478)
2. Katritsis DG, Ioannidis JPA. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation. 2005;111(22):2906-2912. (Pubitemid 40823048)
3. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-1516. (Pubitemid 46588415)
4. Maron DJ, Boden WE, O'Rourke RA, et al. Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial. J Am Coll Cardiol. 2010;55(13):1348-1358.
5. Boden WE, O'Rourke RA, Teo KK, et al. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial). Am J Cardiol. 2009;104(1):1-4.
6. Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359(7):677-687.
7. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation. 2006;113(19):2363-2372.
8. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics: 2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18-e209.
9. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993;342(8883):1317-1322. (Pubitemid 23345178)
10. Davis DA, Taylor-Vaisey A. Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ. 1997;157(4):408-416. (Pubitemid 27384745)
11. Stafford RS, Bartholomew LK, Cushman WC, et al. Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use. Arch Intern Med. 2010;170(10):851-858.
12. Lin GA, Redberg RF, Anderson HV, et al. Impact of changes in clinical practice guidelines on assessment of quality of care. Med Care. 2010;48(8):733-738.
13. Maddox TM, Ho PM, Roe M, Dai D, Tsai TT, Rumsfeld JS. Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the National Cardiovascular Data Registry Cath-PCI Registry. Circ Cardiovasc Qual Outcomes. 2010;3(6):632-641.
14. ISI Web of Knowledge citation search for COURAGE trial. http://apps.isiknowledge.com/. Accessed April 14, 2011.
15. Brindis RG, Fitzgerald S, Anderson HV, Shaw RE, Weintraub WS, Williams JF. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol. 2001;37(8):2240-2245.
16. Krone RJ, Shaw RE, Klein LW, et al. Ad hoc percutaneous coronary interventions in patients with stable coronary artery disease: a study of prevalence, safety, and variation in use from the American College of Cardiology National Cardiovascular Data Registry (ACC-NCDR). Catheter Cardiovasc Interv. 2006;68(5):696-703. (Pubitemid 44721089)
17. Anderson HV, Shaw RE, Brindis RG, et al. Riskadjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendations. Am J Cardiol. 2007;99(2):189-196. (Pubitemid 46072758)
18. American College of Cardiology National Cardiovascular Data Registry. http://www.ncdr.com/webncdr/common/. Accessed April 14, 2011.
19. Fraker TD Jr, Fihn SD, Gibbons RJ, et al. 2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina. Circulation. 2007;116(23):2762-2772. (Pubitemid 350291248)
20. Maron DJ, Boden WE, Weintraub WS, Calfas KJ, O'Rourke RA. Is optimal medical therapy as used in the COURAGE trial feasible for widespread use? Curr Treat Options Cardiovasc Med. 2011;13(1):16-25.
21. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635-2645. (Pubitemid 36741592)
22. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics: 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):e21- e181.
23. Roe MT, Parsons LS, Pollack CV Jr, et al. Quality of care by classification ofmyocardial infarction: treatment patterns for ST-segment elevation vs non-ST-segment elevation myocardial infarction. Arch Intern Med. 2005;165(14):1630-1636. (Pubitemid 41124158)
24. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52(5):818-827.
25. Hyre AD, Muntner P, Menke A, Raggi P, He J. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol. 2007;17(7):548-555. (Pubitemid 46950925)
26. Mehta RH, Roe MT, Chen AY, et al. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. Arch Intern Med. 2006;166(18):2027-2034. (Pubitemid 44537186)
27. Steinberg BA, Steg PG, Bhatt DL, et al. Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry). Am J Cardiol. 2007;99(9):1212-1215. (Pubitemid 46659862)
28. Stafford RS, Radley DC. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol. 2003;41(1):56-61.
29. Atwater BD, Oujiri J, Wolff MR. The immediate impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial on the management of stable angina. Clin Cardiol. 2009;32(8):E1-E3.
30. Veteran's Affairs Cooperative Studies Program. http://www.research.va. gov/programs/pride/conferences/docs/accountability/csp.ppt. Accessed April 14, 2011.
31. Riley RF, Don CW, Powell W, Maynard C, Dean LS. Trends in coronary revascularization in the United States from 2001 to 2009: recent declines in percutaneous coronary intervention volumes. Circ Cardiovasc Qual Outcomes. 2011;4(2):193-197.
32. Ahmed B, Dauerman HL, Piper WD, et al. Recent changes in practice of elective percutaneous coronary intervention for stable angina [published online April 19, 2011]. Circ Cardiovasc Qual Outcomes. doi: 10.1161/circoutcomes.110. 957175.
33. Patient Protection and Affordable Care Act 2010. http://docs.house.gov/ energycommerce/ppacacon.pdf. Accessed April 14, 2011.
34. Avorn J, Fischer M. "Bench to behavior": translating comparative effectiveness research into improved clinical practice. Health Aff (Millwood). 2010; 29(10):1891-1900.
35. Bonham AC, Solomon MZ. Moving comparative effectiveness research into practice: implementation science and the role of academic medicine. Health Aff (Millwood). 2010;29(10):1901-1905.
36. Kereiakes DJ, Teirstein PS, Sarembock IJ, et al. The truth and consequences of the COURAGE trial. J Am Coll Cardiol. 2007;50(16):1598-1603. (Pubitemid 47542361)
37. Association of American Medical Colleges. Industry Funding of Medical Education: Report of an AAMC Task Force. Washington, DC: Association of American Medical Colleges; 2008.
38. Davis D, O'Brien MAT, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA. 1999;282(9):867-874.
39. Lin GA, Dudley RA, Redberg RF. Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease. Arch Intern Med. 2007;167(15):1604-1609. (Pubitemid 47280340)
40. Krumholz HM, Radford MJ,Wang Y, Chen J, Heiat A, Marciniak TA.National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA. 1998;280(7):623-629.
41. Butler J, Arbogast PG, BeLue R, et al. Outpatient adherence to beta-blocker therapy after acute myocardial infarction. J Am Coll Cardiol. 2002;40(9): 1589-1595. (Pubitemid 35253636)
42. Gattis WA, O'Connor CM. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure. Am J Cardiol. 2004;93(9A):74B-76B.
43. Yan AT, Yan RT, Tan M, et al. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome. Am Heart J. 2007;154(6):1108-1115. (Pubitemid 350123528)